VANCOUVER, BC / ACCESSWIRE / September 28, 2016 / CIBT Education Group Inc. (TSX: MBA, OTCQX International: MBAIF) (“CIBT”) is pleased to announce that approximately $16.85 million in subscription funds and signed unit subscription agreements have been received from qualified investors for the purchase of limited partnership units in connection with the GEC Education Mega Center and GEC Education Super Center flagship projects. The subscriptions will be closed in a series of tranches throughout September and October. Proceeds from these subscriptions will be used by the respective limited partnerships to acquire the lands and to provide deposits for construction of the GEC Super Center and GEC Mega Center.

“We are very pleased to have received such high level of interest in a very short time for our GEC flagship projects,” commented Toby Chu, Chairman, President and CEO of CIBT Education Group. “We expect that the first phase financing raising approximately $17 million will soon be fully subscribed, and the limited partnerships will then proceed with phase 2 of the equity raise of approximately $100 million. These private placements are being conducted through limited partnerships managed by a subsidiary of CIBT and therefore, there is no share dilution to CIBT shareholders. These flagship projects will generate substantial structuring fees and are expected to also generate significant management income and capital gains to the benefit of CIBT and its shareholders.”

About CIBT Education Group:

CIBT Education Group Inc. is an education and student-housing investment company focused on the global education market since 1994. Listed on the Toronto Stock Exchange and OTCQX International, CIBT owns and operates a network of business, technical and language colleges in North America and Asia. CIBT offers cooperative joint programs in various countries with campuses, offices and training centers at 27 locations enrolling over 8,300 students annually. Its education business is operated through Sprott Shaw College (established in 1903), Vancouver International College and CIBT School of Business. Through these subsidiaries, CIBT offers recognized and approved business and management degrees, programs in college preparation, healthcare, hotel management, English language training, and over 150 career and vocational programs. CIBT also owns Irix Design Group, a leading design and advertising company based in Vancouver, Canada, Global Education Alliance (“GEA”) and Global Education City Holdings Inc. (“Global Education Holdings”). GEA recruits international students for many elite kindergarten, primary, secondary schools and universities in North America. Global Education Holdings is an investment holding and management company with a special focus on education related real estate projects in Canada such as student hotels, serviced apartments and education super centers. Visit us online at www.cibt.net, www.studenthotel.ca and watch our corporate video at http://cibt.net/about/.

Toby Chu
President, CEO and Chairman
CIBT Education Group Inc.
Investor Relations Contact: 1-604-871-9909 extension 318 or | Email: info@cibt.net

FORWARD-LOOKING STATEMENTS:

Some statements in this news release contain forward-looking information (the “forward-looking statements”) about CIBT Education Group Inc. and its future plans. Forward-looking statements are statements that are not historical facts and in this news release include the statements as to the expected financings for the GEC Education Mega Center and GEC Education Super Center projects, the intended use of proceeds, and that significant management income and capital gains are anticipated. The forward-looking statements are subject to various risks, uncertainties and other factors (collectively, “Risks”) that could cause CIBT’s actual results or achievements to differ materially from those expressed in or implied by forward-looking statements. The Risks include, without limitation, the ability to raise the uncommitted portion of the total equity investment and secure other required funding to acquire the project and pay the required construction deposits, usual construction risks, the ability to obtain all required municipal approvals, and future real estate appreciation. Forward-looking statements are based on the beliefs, opinions and expectations of CIBT’s management at the time they are made, and CIBT does not assume any obligation to update its forward-looking statements if those beliefs, opinions or expectations, or other circumstances should change, except as may be required by law.

SOURCE: CIBT Education Group Inc.

ReleaseID: 446178

LITTLE FALLS, NJ / ACCESSWIRE / September 28, 2016 / Cantel Medical Corp. (NYSE: CMN) will host a conference call and live webcast to discuss the results of the fourth quarter and fiscal year 2016, to be held Thursday, September 29, 2016 at 11:00 AM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

Date, Time: September 29, 2016 at 11 AM ET
Toll Free: 877-407-8033
International: 201-689-8033
Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175293 OR www.cantelmedical.com

Replay Information

The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight eastern on November 29, 2016.

Toll Free: 877-660-6853
International: 201-612-7415
Replay ID#: 13645489
Webcast: www.investorcalendar.com or www.cantelmedical.com

About Cantel Medical Corp.

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.

SOURCE: Investor Calendar

ReleaseID: 445851

VANCOUVER, BC / ACCESSWIRE / September 28, 2016 / Historical exploration at the rice Creek Project from 2008 has reported assays (Otterborn Resources, 2008) from 67 to 937 grams per tonne Ag and 0.2 to 3.29grams per tonne Au. Zinc and lead returned moderate to high results with peak assays of 18% and 16% respectively. Selected assays are summarized in the table:

Locality
Ag/t
Au/t
 
Locality
Ag/t
Au/t
Marc
67
2.49
 
Creek
559
3.29
Marc
99
3.3
 
Lucky Jack
937
2.78
Main
287
1.31
 
Cat
452
1.73
Main
234
1.48
 
Main
204
0.2
Main
492
0.94
 
Main
391
1.07
Main
274
1.77
 
Knoll View
647
1.38
 

Jaxon Minerals Inc. (TSXV: JAX) (“Jaxon”) is pleased to announced a letter of intent has been signed to purchase the Ag-Zn-Pb-Au Price Creek massive sulfide Property (“Property”) from CJL Enterprises Ltd. (“Vendor”). The 2396 ha. Property is located in the Price Creek valley of north-central British Columbia, approximately 55 kilometres north of the town of Smithers.

The property hosts two known showings: The Knoll Zn-Pb-Ag-Au (Minfile 093M 100) and the more expansive Max Ag-Au-Zn-Pb occurrence (Minfile 093M 027) with at least 19 distinctive massive sulfide-bearing outcrops distributed over a 700 metre by 1000 metre area that have been subject to numerous exploration programs in the past years.

A Report in the year 2000 (Wojdak and Ethier) noted the mineralization cut by drilling in the Knoll area is similar in style to that mined at Eskay Creek, and that the same style was observed in massive stratiform polymetallic mineralization at the adjacent Max area.

The property has at least four known styles of mineralization:

1) Stratiform, bedding parallel sulfide mineralization (up to 1.5 metres thick) that was probably related to a shallow marine, VMS exhalative (hot spring) hydrothermal system. It is seen in the Max area at the “Creek” “Max Main Trench”, “Forgotten”, “Lower Forgotten” and “Knoll View” occurrences. In the Max area, the zones of stratiform sulfide mineralization include pyrite, arsenopyrite, galena, sphalerite, jamesonite, stibnite and gold.

2) Sulfide-bearing veins hosted in the Cretaceous Max Stock and its hornfelsic envelope. These north to northeast striking veins contain of pyrite and arsenopyrite; a 15 centimetre chip sample across the Spine assayed 12.7g/t Au (BC Minfle).

3) Sediment-hosted veins, up to 1.5 metre wide, that contain variable quantities of pyrite, arsenopyrite, galena, sphalerite, stibnite, gold and possible some Ag bearing minerals, including sulfosalts.

4) Rhyolite-hosted disseminated pyrite and sphalerite which has only been identified in some drill-holes from the Knoll area.

The terms of the Letter of Intent are:

1) Payment of $5,000 on signing the letter of intent

2) Issuance of 100,000 shares to the vendor on approval by the TSX. Venture Exchange.

Issuance of 100,000 shares to the vendor for each of the next subsequent four years on the anniversary of the TSX. Venture Exchange acceptance and,

3) Make cash payments of:

$10,000 on year one anniversary
$15,000 on year two of anniversary
$20,000 on year three of anniversary
$25,000 on year four of anniversary

4) An advance royalty of $5,000 per year is to commence in year five. An NSR of 2% on production can be purchased for $1,000,000 for each percent in the event of commercial production. A further 200,000 shares will be issued to the vendor.

The technical content of this News Release has been reviewed and approved by Glen Macdonald, P.Geo., who is a qualified person under the definition of National Instrument 43-101.

Leif Smither, President of Jaxon stated: “There is an impressive amount of mineral on the Price Creek Proerty with 19 showings and four distinctive styles of mineralization. Jaxon is well positioned to take advantage of this and make a discovery. I am looking forward to having our technical team work on the property.”

The Company also advises that the private placement announced on May 4, 2016 will now be reestablished with similar terms but in an increased amount. The placement will now be up to 10,500,000 units at $0.07 per unit to raise gross proceeds of up to $735,000 (the offering). Each unit will be comprised of one common share and one-half common share purchase warrant. Each whole share purchase warrant will entitle the holder to purchase one common share at $0.10 per share with an expiring date of one year from the closing of the private placement. A finder’s fee commensurate with TSX.V policies will be paid where applicable.

The funds raised will be used to conduct exploration on the Company’s Hot Bath Project, located in British Columbia between the communities of Dease Lake, Iskut and for the exploration on the Price Creek Project near Smithers, BC. and for working capital.

ON BELHALF OF THE BOARD OF DIRECTORS
JAXON MINERALS INC.

“Leif Smither”
Leif Smither, President

For further information regarding Jaxon Minerals Inc., please contact:

Leif Smither
604-608-0400
Toll free: 1-877-608-0007

This news release may contain forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release may include, but is not limited to, the Company’s objectives, goals or future plans. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, those risks set out in the Company’s public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither TSX Venture exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Venture Exchange accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Jaxon Minerals Inc.

ReleaseID: 446177

KELOWNA, BC / ACCESSWIRE / September 28, 2016 / Marapharm Ventures Inc. (“Marapharm”) (CSE: MDM), (FSE: 2M0), (OTCQB: MRPHF), is pleased to announce a non-brokered private placement of secured convertible bonds for gross proceeds of up to $5,500,000 USD at an issue price of $10,000 per bond, bearing compound interest at the annual rate of 8.5% until the maturity date of November 30, 2019. The offering is open for subscription until November 30, 2016, or until determined by the directors of Marapharm, and may be closed in tranches. The proceeds from the private placement will be used as a debt facility for Marapharm Las Vegas, LLC (“MLV”) and the bonds will be secured by the assets of MLV, which include real property, buildings, 3 special use licenses for 300,000 square feet of medical marijuana cultivation, and equipment. The bonds will be open for prepayment without penalty, with monthly payments of principal and interest beginning 4 months from the closing date. In addition, Marapharm has agreed to issue a 3% bonus (or $300) for each bond issued, such bonus to be payable with Marapharm common shares at a deemed price of $0.75 per share on the closing date. The bonds, in part or full, will be convertible into common shares of Marapharm at the conversion price of $1.00 per share for year 1, $2.00 per share for year 2, and $3 per share for year 3. A finder’s fee of up to 10% is payable to finders. MLV intends to use the net proceeds of the private placement to pay for equipment, operating capital costs, and construction of MLV starter facilities for growing, testing, and staffing operations in Las Vegas, Nevada.

ABOUT MARAPHARM VENTURES INC.
www.marapharm.com

Additional information on the operations or financial results of Marapharm are included in reports on file with applicable securities regulatory authorities and may be accessed through the CSE website (www.thecse.com), the OTC website (www.otcmarkets.com) and Sedar website (www.sedar.com) under the profile for Marapharm Ventures Inc.

FOR FURTHER INFORMATION:
www.marapharm.com or Linda Sampson, CEO, 778-583-4476 info@marapharm.com

STOCK EXCHANGES:

Neither the CSE, the FSE nor the OTCQB® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQB® accepts responsibility for the adequacy or accuracy of this release.

FORWARD – LOOKING STATEMENTS:
Certain statements contained in this news release constitute forward looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe”, and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.

SOURCE: Marapharm Ventures Inc.

ReleaseID: 446176

IRVINE, CA / ACCESSWIRE / September 28, 2016 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit has been filed against Twitter, Inc. (“Twitter” or the “Company”) (NYSE: TWTR). Investors who purchased or otherwise acquired shares between February 6, 2015 and July 28, 2015 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the November 15, 2016 lead plaintiff motion deadline.

If you purchased Twitter shares during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that during the Class Period, Twitter made materially false and/or misleading statements and/or failed to disclose: that by early 2015 daily active users had replaced the timeline views metric as the primary user engagement metric tracked internally by Twitter management; that the trend in user engagement growth was flat or declining; that new product initiatives were not having a significant impact on monthly active users or user engagement; that the Company’s stated “acceleration” was the result of low-quality monthly active user growth; and that Twitter lacked a basis for its previously issued projections of approximately 20% monthly active user growth and 550 million monthly active users in the immediate term.

If you wish to learn more about this lawsuit, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 446173

LOS ANGELES, CA / ACCESSWIRE / September 28, 2016 / Lundin Law PC (the “Firm”) announces the filing of a class action lawsuit against AECOM (“AECOM” or the “Company”) (NYSE: ACM) concerning possible violations of federal securities laws between February 11, 2015 and August 15, 2016 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the October 31, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The complaint alleges that during the Class Period, AECOM made false and/or misleading statements and/or failed to disclose that: the Company engaged in fraudulent and deceptive business practices; that AECOM lacked effective internal controls over financial reporting; that the Company overstated the benefits of its acquisition of URS Corp.; that AECOM overstated its free cash flow per share; and that as a result of the above, AECOM’s public statements were materially false and misleading at all relevant times. On August 16, 2016, Spruce Point Capital Management published a report on AECOM asserting that the Company’s stock is worth 33%-45% less than its current price on the market. When this news was made public, the stock price of AECOM declined, thus causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 446171

LOS ANGELES, CA / ACCESSWIRE / September 28, 2016 / Lundin Law PC (the “Firm”) announces the filing of a class action lawsuit against American Renal Associates Holdings, Inc. (“ARA” or the “Company”) (NYSE: ARA) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares 1) pursuant and/or traceable to the Initial Public Offering (“IPO”) on or about April 21, 2016; and/or 2) on the open market between April 21, 2016 and August 18, 2016 (the “Class Period”), should contact the Firm in advance of the October 31, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The complaint alleges that ARA issued false and misleading statements to investors and/or failed to disclose that: the Company was engaged in a fraudulent scheme to steer patients away from Medicare and Medicaid plans they qualified for, into more expensive Affordable Care Act plans to obtain greater reimbursement for its dialysis services; the scheme was in violation of federal and state laws; and as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this information emerged to the public, the stock price of ARA fell, which caused investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 446172